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Abstract This study aimed at validating an existing health-
related quality of life questionnaire for patients with facial
palsy for implementation in the Dutch language and culture.
The Facial Clinimetric Evaluation Scale was translated into
the Dutch language using a forward–backward translation
method. A pilot test with the translated questionnaire was
performed in 10 patients with facial palsy and 10 normal
subjects. Finally, cross-cultural adaption was accomplished at
our outpatient clinic for facial palsy. Analyses for internal
consistency, test–retest reliability, construct validity and
responsiveness were performed. Ninety-three patients com-
pleted the Dutch Facial Clinimetric Evaluation Scale, the
Dutch Facial Disability Index, and the Dutch Short Form (36)
Health Survey. Cronbach’s a, representing internal consis-
tency, was 0.800. Test–retest reliability was shown by an
intraclass correlation coefficient of 0.737. Correlations with
the House–Brackmann score, Sunnybrook score, Facial Dis-
ability Index physical function, and social/well-being function
were -0.292, 0.570, 0.713, and 0.575, respectively. The SF-
36 domains correlate best with the FaCE social function
domain, with the strongest correlation between the both social
function domains (r = 0.576). The FaCE score did statisti-
cally significantly increase in 35 patients receiving botulinum
toxin type A (P = 0.042, Student t test). The domains ‘facial
comfort’ and ‘social function’ improved statistically signifi-
cantly as well (P = 0.022 and P = 0.046, respectively, Stu-
dent t-test). The Dutch Facial Clinimetric Evaluation Scale
shows good psychometric values and can be implemented in
the management of Dutch-speaking patients with facial palsy
in the Netherlands. Translation of the instrument into other
languages may lead to widespread use, making evaluation
and comparison possible among different providers.
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Introduction
Patients experiencing peripheral facial palsy experience
both functional and psychosocial consequences. The eval-
uation of both aspects is fundamental in the management of
facial palsy. Among the consequences of peripheral facial
palsy are brow ptosis, incomplete eye closure (leading to
exposure keratopathy), external nasal valve collaps, oral
incompetence, speech and articulation problems, synkine-
sis (involuntary movement during voluntary movement),
esthetic impairments, and the inability to express emotions,
sometimes leading to social isolation.
Assessment of facial function in peripheral facial palsy
comprises different perspectives; evaluation by a physician
using grading scales [1, 2], objective (sometimes automated)
measurement methods [3–5], and patient self-assessment
using questionnaires. In an era of rapid developments in
computerized, automated measurement tools, the influence
of the disease on the patient’s quality of life must not be
overlooked, and should be considered an essential feature of
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clinical assessment, and remains important during first
consultation, during follow-up, and after treatment.
The self-assessment of patients using questionnaires gives
an impression of the influence of disease on quality of life. For
this purpose, nondisease-specific questionnaires exist [6, 7], as
well as disease-specific questionnaires, though very few of
them are adapted in regular clinical practice. Kahn et al. [8]
developed an instrument which covers both the functional and
psychosocial aspect of facial palsy, the Facial Clinimetric
Evaluation Scale (FaCE Scale). This questionnaire consists of
15 questions with a 5-point Likert scale. The FaCE Scale
comprises six domains; facial movement, facial comfort, oral
function, eye comfort, lacrimal control, and social function.
Total and domain scores range from 0 (worst) to 100 (best).
The FaCE Scale is a valid, reliable, and easily admin-
istered instrument [8]. Since its original description, this
questionnaire has been used in several studies showing
patient satisfaction following treatment [9–12]. We wanted
to implement this instrument in the Dutch-speaking popu-
lation in the Netherlands, both because we want to use an
instrument that covers both functional and psychosocial
domains and also so that we may compare our treatment
and recovery results with international results.
In the current literature there is no consensus on ‘gold
standard’ guidelines for translating quality of life ques-
tionnaires. Two methods are described: the forward–
backward translation [13–15] and the dual panel translation
[16]. Dual panel translation compromises the translation by
a team of translators working together and assessment of
the translation by a lay panel [17]. The forward–backward
translation seems to be the most accepted method, although
there is no evidence to support this view. Acquadro et al.
[17] performed a literature review in 2008; they did not
find evidence in favor of one method, but strongly advised
researchers to adopt a multistep approach. When using a
questionnaire in another country and another language,
translation of the items alone is not enough. The items must
be adapted to the new culture to maintain the content
validity of the instrument: cross-cultural adaption is
required. [18, 19].
The aim of this study was to create a Dutch version of
the FaCE Scale and to test its internal consistency, test–
retest reliability, construct validity, and responsiveness for
a valid use in the Dutch language and culture.
Materials and methods
Translation
The study protocol was assessed according to guidelines of
the local committee on research involving human subjects;
no formal ethical review was required.
We approached the developers of the FaCE Scale and
obtained permission to use the instrument for translation
and validation [8]. A forward–backward translation
approach was used in this study (Fig. 1). Considerations
and difficulties of each step were documented. Choice of
wording and phraseology had to be compatible with a
reading level of age 14 [13]. The pilot test was performed
in a group of ten patients with a facial palsy and ten per-
sons without history of facial disease. Respondents com-
pleted the questionnaire and were asked about difficulties
with answering and understanding the items. After this
pilot test, final adjustments were made and documented.
Validation
Validation of the Dutch FaCE Scale was performed at our
university medical center between December 2012 and
August 2014. Dutch-speaking adult (18 years or older)
patients with a facial palsy were included. Patients com-
pleted three different questionnaires: (1) the Dutch FaCE
Scale, and to test construct validity (2) the Dutch Facial
Disability Index (FDI), and (3) the Dutch Short Form (36)
Health Survey (SF-36). All responses were entered in IBM
SPSS Statistics 20 (IBM Corp. Armonk, NY) according to
the principle of double data entry. In addition, gender, age,
etiology, side and duration of the palsy, House-Brackmann
(HB) scores, and Sunnybrook (SB) scores were collected in
the database. This information was retrieved from the
medical charts retrospectively, so missing data could occur.
Patients not receiving any form of treatment were sent the
Dutch FaCE Scale again after 2 weeks for test–retest reli-
ability. At the end of the study, to increase the response rate
for test–retest, patients were sent the Dutch FaCE Scale
(plus FDI and SF-36) 2 weeks before visiting our clinic and
the test–retest was performed during their visit, indepen-
dent in the waiting room. Patients receiving treatment with
botulinum toxin type A for synkinesis were sent the Dutch
FaCE Scale 4 weeks after injection to test the responsive-
ness of the questionnaire.
Facial Disability Index
The FDI is a disease-specific quality of life questionnaire
for patients with facial palsy, developed at the Facial Nerve
Center in Pittsburg around 1996 by VanSwearingen et al.
[20]. The FDI has two domains: physical function and
social/well-being function. The physical function scores
range from -25 (worst) to 100 (best), and the social/well-
being function scores range from 0 (worst) to 100 (best).
This questionnaire has been translated into Dutch accord-
ing to a forward–backward method previously (not pub-
lished), but has not officially been validated for use in the
Dutch culture.
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The short form (36) health survey
The SF-36 is a general health-related quality of life ques-
tionnaire, consisting of 36 questions. All questions save
one (item 2) are converted in eight domains: physical
functioning (PF), role limitations due to physical health
problems (RP), bodily pain (BP), general health percep-
tions (GH), vitality (VT), social functioning (SF), role
limitations due to emotional problems (RE), and mental
health (MH). The scores range from 0 (worst) to 100 (best).
This self-report health status questionnaire is the most
widely used instrument and has been translated for use in
more than 40 countries (including Dutch) [6, 21].
Statistical analysis
IBM SPSS Statistics 20 (IBM Corp. Armonk, NY) was
used for data collection and statistical analysis. First,
descriptive analyses were performed to show patient
characteristics. Cronbach’s a coefficient was calculated to
test the internal consistency of the Dutch FaCE Scale.
Intra-class correlation was calculated to analyze test–retest
reliability. Correlations between the Dutch FaCE Scale and
the HB score, SB score, FDI, and SF-36 were calculated
using Spearman’s rank correlation coefficient to show
construct validity. To test responsiveness, a paired samples
t-test was performed. [22].
Results
Pilot testing
Ten normal subjects, without history of facial disease,
completed the pilot version of the Dutch FaCE Scale; they
all had a FaCE score of 100 (best score). Ten patients with
peripheral facial palsy completed the pilot version of the
translated questionnaire as well. Subjects did not document
any difficulties in understanding or answering the items,
and no further changes were made in the Dutch FaCE
Scale.
Validation
Between December 2012 and September 2014, 93 patients
completed the Dutch FaCE Scale, FDI, and SF-36. Patient
characteristics are shown in Table 1.
The category ‘‘other etiologies’’ comprised Lyme dis-
ease, congenital facial palsy, traumatic cases, parotid
malignancies, cholesteatoma, and benign facial nerve
tumors. FaCE scores are shown in Table 2.
The internal consistency of the Dutch FaCE Scale was
tested by Cronbach’s a, which showed a value of 0.80.
A Cronbach’s a[0.7 is generally considered acceptable,
and a[ 0.8 as good [22]. The Cronbach’s a scores ranged
from 0.57 to 0.84 for the FaCE Scale sub domains
(Table 3). Test–retest reliability was calculated with the
intra-class correlation coefficient (ICC). Forty patients met
the criteria for test–retest reliability analysis, but only 21
patients (53 %) completed the questionnaires at both time
points. Results are shown in Table 3. Test–retest reliability
was demonstrated with ICC’s ranging from 0.65 to 0.80.
Correlations between the FaCE scores and the FDI, SF-
36, HB, and SB scores are shown in Tables 4 and 5.
Fig. 1 Method of translation in this study: * Two independent
translators, both native Dutch with American–English as their second
fluent language; one of them was a medical doctor. # Committee
consisting of the authors of this manuscript. ^ Two independent
translators: both of American origin with Dutch as a second language
and blinded for the original questionnaire; one of them had a medical
background
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Correlation with the HB score is negative because of the
design of the HB (1 is no palsy, 6 is complete flaccid
palsy). A Spearman’s correlation coefficient of 0.570 for
the SB score indicates good construct validity of the Dutch
FaCE Scale. As expected, the HB and SB scores show the
best correlations with the facial movement domain of the
Dutch FaCE Scale (r = -0.410 and r = 0.603, respec-
tively). The total FaCE score correlates well with the FDI
physical function and FDI social/well-being function
scores; r = 0.713 and r = 0.575, respectively. The FDI
social/well-being function has the highest correlation with
the FaCE social function domain (r = 0.729). The FDI
physical function has the highest correlation with the FaCE
oral function domain (r = 0.661). The SF-36 domains
correlate best with the FaCE social function domain, with
the strongest correlation between the both social function
domains (r = 0.576). FaCE domain facial movement
shows the weakest correlations with the SF-36. Since the
SF-36 is a general health-related questionnaire, strong
correlations were not expected.
Responsiveness
Thirty-five patients received treatment for synkinesis with
botulinum toxin A. Nineteen of them (54 %) had received
botulinum toxin previously, and the other 46 % were new
to this treatment. Total FaCE score before treatment was
44.7 (SD 15.0) and about 4 weeks after treatment 48.5 (SD
15.2). This difference is statistically significant
(P = 0.042, Student t-test). The domains ‘facial comfort’
and ‘social function’ improved statistically significantly as
well (P = 0.022 and P = 0.046, respectively, Student t-
test).
Discussion
In this study, the FaCE Scale has been translated and
validated for use in the Netherlands. Good psychometric
values for the Dutch version of the self-assessment ques-
tionnaire are shown. The internal consistency of the Dutch
FaCE Scale is reflected by a Cronbach’s a of 0.80. The
internal consistency of the Swedish and German transla-
tions shows a Cronbach’s a of 0.92 and 0.91, respectively
[23, 24]. A possible explanation for this difference might
be a different patient population used in the different
studies. We compared our patient characteristics with the
Swedish and German study, and they match highly. Other
methodological differences between studies can explain
different outcomes as well, for example, if questionnaires
were completed individually or in company of a physician.
We consider our internal consistency as good, as well as
the test–retest reliability, and construct validity.
Strength of this study
Translation of the FaCE Scale into the Dutch language and
validation for use in the Dutch culture were performed
according to the highest standards for translation of self-
assessment questionnaires [14, 19, 25].
Table 1 Patient characteristics n % Mean SD Median Range
Gender
Female 61 66
Male 32 34
Age (years) 55.1 13.8 55 20–89
Side
Left 43 46
Right 47 51
Bilateral 3 3
Time since onset (months) 45 52 29 4–298
Etiology
Bell’s Palsy 48 52
Ramsay Hunt 16 17
Iatrogenic 7 8
Acoustic neuroma 6 7
other 16 16
House-Brackmann 3.3 1.2 3.0 1–6
Sunnybrook 45.9 20.4 49.0 0–83
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Limitations of this study
Translators (forward and backward) were neither profes-
sional translators, nor experienced in questionnaire trans-
lation, and not familiar with the questionnaire. During both
stages, a translator with a medical background and a lay-
person were chosen; the idea was to produce one transla-
tion that would reflect the concepts of the original
questionnaire and the other translation would reflect the
language used by a layperson. In the literature there is no
consensus on the choice of translators [17].
The FDI we used in this study has not been translated
and validated for use in Dutch according to the current
standards. We could have done this together with the
translation and validation of the FaCE Scale; however, we
have chosen to validate just one questionnaire. Assessment
of the health-related quality of life by the use of two self-
assessment questionnaires seems unnecessary. The FaCE
Scale is the instrument of our choice, based on the study of
Kahn et al. and Ho et al. [8, 26]. Kahn et al. [8] showed that
the mean difference in FDI social/well-being function
scores between subjects with facial palsy and control
subjects was relatively small, indicating that the FDI
instrument does not discriminate as well as the FaCE Scale
between normal and disease states. Ho et al. performed a
systematic review of patient-reported outcome measures in
facial palsy. Three self-assessment questionnaires met their
inclusion and exclusion criteria: the FaCE Scale, the FDI,
Table 2 FaCE Scores (total
and domains)
Mean SD Median Range n
Total Score 44.6 16.4 46.7 3–87 83
Facial Movement Score 33.0 22.3 33.3 0–83 81
Facial Comfort Score 32.2 25.6 25 0–100 83
Oral Function Score 45.6 27.1 50 0–100 83
Eye Comfort Score 41.8 33.6 43.8 0–100 82
Lacrimal Control Score 47.4 28.7 50 0–100 78
Social Function Score 62.3 26.1 62.5 0–100 83
Table 3 Internal consistency
reliability and test–retest
reliability
ICC intraclass correlation
coefficient, CI confidence
interval, # this sub domain has
only one item, for internal
consistency n = 93, for test–
retest reliabilty n = 21
Internal consistency Test–retest
Cronbach’s a ICC 95 % CI
Test Retest
Total Score 0.80 0.81 0.737 0.463–0.883
Facial Movement Score 0.64 0.54 0.653 0.322–0.843
Facial Comfort Score 0.84 0.77 0.802 0.564–0.917
Oral Function Score 0.79 0.90 0.700 0.341–0.872
Eye Comfort Score 0.57 0.43 0.747 0.472–0.891
Lacrimal Control Score # # 0.741 0.427–0.895
Social Function Score 0.75 0.85 0.674 0.350–0.854
Table 4 Correlation between FaCE scores with House-Brackmann scores, Sunnybrook scores, and Facial Disability Index (Spearman’s cor-
relation coefficient)
FaCE scores House-Brackmann
(n = 62)
Sunnybrook
(n = 54)
FDI physical function
(n = 92)
FDI social/well-being function
(n = 92)
Total -0.292* 0.570** 0.713** 0.575**
Facial movement -0.410** 0.603** 0.310** 0.062
Facial comfort 0.134 0.086 0.443** 0.318**
Oral function -0.222 0.385** 0.661** 0.365**
Eye comfort -0.226 0.475** 0.367** 0.108
Lacrimal control 0.006 0.128 0.247* 0.180
Social function -0.119 0.323* 0.477** 0.729**
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and a questionnaire developed by Borodic et al. [9]. The
FaCE Scale met the most psychometric standards [26].
One of the domains of the Dutch FaCE Score (eye
comfort) shows a poor internal consistency (a = 0.57); in
the validation study of Kahn et al., this domain has the
lowest score as well (0.72). A possible explanation for our
low a might be the sample in which the questionnaire was
applied; reliability is a characteristic of the test scores, not
of the test itself; our group might be more heterogeneous in
terms of co morbidity, for example [27].
The response rate for test–retest reliability was quite low
in this study; 40 patients met the criteria for test–retest
reliability analysis, which meant they did not receive any
form of treatment during their visit and received a second
Dutch FaCE Scale per mail after 2 weeks. Only 21 of them
(53 %) completed the questionnaires. We likely could have
increased this response rate if we had been more persistent
in pursuing a response.
Comparison with grading systems
Many different facial grading systems have been developed,
almost all focusing on the physiological and anatomical
abnormalities in the face [28, 29]. The effect of the dis-
ability on the patient’s quality of life is not covered by these
systems, while reduced social functioning after facial palsy
is described in the literature [30]. The extent of physio-
logical impairment is not by definition correlated with
impact on patient quality of life. For example, a patient with
a HB 5 can have very little influence of the palsy on his/her
quality of life, whereas a patient with HB 2 can be com-
pletely socially isolated. Kahn et al. [8] found that the
correlations between the FaCE Scale and physician-graded
scales were not always as expected; for example, the eye
comfort domain of the FaCE Scale did not strongly corre-
late with the physician’s assessment regarding eye closure,
suggesting that the degree of eye closure does not predict
the problems the patient experiences.
Conclusion
The Dutch FaCE Scale is a valid, reliable, and easy-to-
perform instrument for the assessment of the influence of
facial palsy on the patient’s quality of life. The use of the
Dutch FaCE Scale can now be implemented in the man-
agement of patients with facial palsy in our clinic. With
comparable studies in Sweden, China, and Germany, this
self-assessment questionnaire for patients with facial palsy
is now available in five languages [8, 23, 24, 31]. This is a
great step forward in the implementation of a widely used
instrument.
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